share_log

HC Wainwright & Co. Maintains Buy on Actinium Pharma, Maintains $50 Price Target

HC Wainwright & Co. Maintains Buy on Actinium Pharma, Maintains $50 Price Target

HC Wainwright & Co.維持對Actinium Pharma的買入,維持50美元的目標股價
Benzinga ·  03/11 10:37

HC Wainwright & Co. analyst Joseph Pantginis maintains Actinium Pharma (AMEX:ATNM) with a Buy and maintains $50 price target.

HC Wainwright & Co. 分析師約瑟夫·潘吉尼斯維持Actinium Pharma(AMEX: ATNM)的買入並維持50美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論